Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Open-label trial of recombinant human insulin-like growth factor 1/recombinant human insulin-like growth factor binding protein 3 in myotonic dystrophy type 1.

Heatwole CR, Eichinger KJ, Friedman DI, Hilbert JE, Jackson CE, Logigian EL, Martens WB, McDermott MP, Pandya SK, Quinn C, Smirnow AM, Thornton CA, Moxley RT 3rd.

Arch Neurol. 2011 Jan;68(1):37-44. doi: 10.1001/archneurol.2010.227. Epub 2010 Sep 13.

2.

Pregnancy and birth outcomes in women with facioscapulohumeral muscular dystrophy.

Ciafaloni E, Pressman EK, Loi AM, Smirnow AM, Guntrum DJ, Dilek N, Tawil R.

Neurology. 2006 Nov 28;67(10):1887-9.

PMID:
17130433
3.

Efficacy and tolerability of low-dose donepezil in schizophrenia.

Erickson SK, Schwarzkopf SB, Palumbo D, Badgley-Fleeman J, Smirnow AM, Light GA.

Clin Neuropharmacol. 2005 Jul-Aug;28(4):179-84.

PMID:
16062097

Supplemental Content

Loading ...
Support Center